Xynomic Pharmaceuticals IPO

Xynomic Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing oncology drug candidates.

Register for Details

For more details on financing and valuation for Xynomic Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Xynomic Pharmaceuticals's ticker symbol?


Learn more about Xynomic Pharmaceuticals

Forge green plus iconForge green minus icon

What is Xynomic Pharmaceuticals funding to date?

Xynomic Pharmaceuticals has raised $21.8MM to date.
Forge green plus iconForge green minus icon

When was Xynomic Pharmaceuticals founded?

Xynomic Pharmaceuticals was founded in 2016.
Updated on: Jun 12, 2022


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.